Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2017, Article ID 2740768, 13 pages
https://doi.org/10.1155/2017/2740768
Review Article

The Function of FGFR1 Signalling in the Spinal Cord: Therapeutic Approaches Using FGFR1 Ligands after Spinal Cord Injury

Neurorestoration Group, Wolfson Centre for Age-Related Diseases, King’s College London, London SE1 1UL, UK

Correspondence should be addressed to Barbara Haenzi; ku.ca.mac@234hb

Received 14 July 2016; Accepted 25 December 2016; Published 18 January 2017

Academic Editor: Lin Xu

Copyright © 2017 Barbara Haenzi and Lawrence D. F. Moon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. M. Bareyre, M. Kerschensteiner, O. Raineteau, T. C. Mettenleiter, O. Weinmann, and M. E. Schwab, “The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats,” Nature Neuroscience, vol. 7, no. 3, pp. 269–277, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Hagg and M. Oudega, “Degenerative and spontaneous regenerative processes after spinal cord injury,” Journal of Neurotrauma, vol. 23, no. 3-4, pp. 264–280, 2006. View at Google Scholar · View at Scopus
  3. X. Ling and D. Liu, “Temporal and spatial profiles of cell loss after spinal cord injury: reduction by a metalloporphyrin,” Journal of Neuroscience Research, vol. 85, no. 10, pp. 2175–2185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. G. Waxman, “Demyelination in spinal cord injury,” Journal of the Neurological Sciences, vol. 91, no. 1-2, pp. 1–14, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. G. S. Basi, R. D. Jacobson, I. Virág, J. Schilling, and J. H. P. Skene, “Primary structure and transcriptional regulation of GAP-43, a protein associated with nerve growth,” Cell, vol. 49, no. 6, pp. 785–791, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Blackmore, Z. Wang, J. K. Lerch et al., “Krüppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 19, pp. 7517–7522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. D. L. Moore, M. G. Blackmore, Y. Hu et al., “KLF family members regulate intrinsic axon regeneration ability,” Science, vol. 326, no. 5950, pp. 298–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Chew, J. W. Fawcett, and M. R. Andrews, “The challenges of long-distance axon regeneration in the injured CNS,” Progress in Brain Research, vol. 201, pp. 253–294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Fawcett and R. A. Asher, “The glial scar and central nervous system repair,” Brain Research Bulletin, vol. 49, no. 6, pp. 377–391, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. Schwab and D. Bartholdi, “Degeneration and regeneration of axons in the lesioned spinal cord,” Physiological Reviews, vol. 76, no. 2, pp. 319–370, 1996. View at Google Scholar · View at Scopus
  11. C. C. Stichel and H. W. Müller, “The CNS lesion scar: new vistas on an old regeneration barrier,” Cell and Tissue Research, vol. 294, no. 1, pp. 1–9, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Giulian and C. Robertson, “Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord,” Annals of Neurology, vol. 27, no. 1, pp. 33–42, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. E. D. Means and D. K. Anderson, “Neuronophagia by leukocytes in experimental spinal cord injury,” Journal of Neuropathology and Experimental Neurology, vol. 42, no. 6, pp. 707–719, 1983. View at Publisher · View at Google Scholar · View at Scopus
  14. C. H. Tator and M. G. Fehlings, “Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms,” Journal of Neurosurgery, vol. 75, no. 1, pp. 15–26, 1991. View at Publisher · View at Google Scholar · View at Scopus
  15. L. L. Jones, Y. Yamaguchi, W. B. Stallcup, and M. H. Tuszynski, “NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors,” Journal of Neuroscience, vol. 22, no. 7, pp. 2792–2803, 2002. View at Google Scholar · View at Scopus
  16. L. L. Jones, R. U. Margolis, and M. H. Tuszynski, “The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury,” Experimental Neurology, vol. 182, no. 2, pp. 399–411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Bruce, M. D. Norenberg, S. Kraydieh, W. Puckett, A. Marcillo, and D. Dietrich, “Schwannosis: role of gliosis and proteoglycan in human spinal cord injury,” Journal of Neurotrauma, vol. 17, no. 9, pp. 781–788, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. Guest, E. D. Hiester, and R. P. Bunge, “Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury,” Experimental Neurology, vol. 192, no. 2, pp. 384–393, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. E. Bandtlow and M. E. Schwab, “NI-35/250/Nogo-A: a neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adult vertebrate CNS,” GLIA, vol. 29, no. 2, pp. 175–181, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. E. J. Bradbury, L. D. F. Moon, R. J. Popat et al., “Chondroitinase ABC promotes functional recovery after spinal cord injury,” Nature, vol. 416, no. 6881, pp. 636–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. D. A. Morgenstern, R. A. Asher, and J. W. Fawcett, “Chondroitin sulphate proteoglycans in the CNS injury response,” Progress in Brain Research, vol. 137, pp. 313–332, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Anderson, J. E. Burda, Y. Ren et al., “Astrocyte scar formation AIDS central nervous system axon regeneration,” Nature, vol. 532, no. 7598, pp. 195–200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Turner and R. Grose, “Fibroblast growth factor signalling: from development to cancer,” Nature Reviews Cancer, vol. 10, no. 2, pp. 116–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Doherty, J. Cohen, and F. S. Walsh, “Neurite outgrowth in response to transfected N-CAM changes during development and is modulated by polysialic acid,” Neuron, vol. 5, no. 2, pp. 209–219, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. E. J. Williams, F. S. Walsh, and P. Doherty, “Tyrosine kinase inhibitors can differentially inhibit integrin-dependent and CAM-stimulated neurite outgrowth,” Journal of Cell Biology, vol. 124, no. 6, pp. 1029–1037, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. E. J. Williams, J. Furness, F. S. Walsh, and P. Doherty, “Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin,” Neuron, vol. 13, no. 3, pp. 583–594, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Doherty and F. S. Walsh, “CAM-FGF receptor interactions: a model for axonal growth,” Molecular and Cellular Neurosciences, vol. 8, no. 2-3, pp. 99–111, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. E. J. Williams, F. S. Walsh, and P. Doherty, “The production of arachidonic acid can account for calcium channel activation in the second messenger pathway underlying neurite outgrowth stimulated by NCAM, N-cadherin, and L1,” Journal of Neurochemistry, vol. 62, no. 3, pp. 1231–1234, 1994. View at Google Scholar · View at Scopus
  29. L. A. Matsuda, S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner, “Structure of a cannabinoid receptor and functional expression of the cloned cDNA,” Nature, vol. 346, no. 6284, pp. 561–564, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. W. A. Devane, F. A. Dysarz III, M. R. Johnson, L. S. Melvin, and A. C. Howlett, “Determination and characterization of a cannabinoid receptor in rat brain,” Molecular Pharmacology, vol. 34, no. 5, pp. 605–613, 1988. View at Google Scholar · View at Scopus
  31. C. M. Gerard, C. Mollereau, G. Vassart, and M. Parmentier, “Molecular cloning of a human cannabinoid receptor which is also expressed in testis,” Biochemical Journal, vol. 279, no. 1, pp. 129–134, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Munro, K. L. Thomas, and M. Abu-Shaar, “Molecular characterization of a peripheral receptor for cannabinoids,” Nature, vol. 365, no. 6441, pp. 61–65, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. T. F. Freund, I. Katona, and D. Piomelli, “Role of endogenous cannabinoids in synaptic signaling,” Physiological Reviews, vol. 83, no. 3, pp. 1017–1066, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Pacher, S. Bátkai, and G. Kunos, “The endocannabinoid system as an emerging target of pharmacotherapy,” Pharmacological Reviews, vol. 58, no. 3, pp. 389–462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. C. He, I. Gomes, T. Nguyen et al., “The Gαo/i-coupled cannabinoid receptor-mediated neurite outgrowth involves rap regulation of Src and Stat3,” Journal of Biological Chemistry, vol. 280, no. 39, pp. 33426–33434, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. C. He, S. R. Neves, J. D. Jordan, and R. Iyengar, “Role of the Go/i signaling network in the regulation of neurite outgrowth,” Canadian Journal of Physiology and Pharmacology, vol. 84, no. 7, pp. 687–694, 2006. View at Publisher · View at Google Scholar
  37. M. J. Crowe, J. C. Bresnahan, S. L. Shuman, J. N. Masters, and M. S. Beattie, “Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys,” Nature Medicine, vol. 3, no. 1, pp. 73–76, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. M. O. Totoiu and H. S. Keirstead, “Spinal cord injury is accompanied by chronic progressive demyelination,” Journal of Comparative Neurology, vol. 486, no. 4, pp. 373–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Jasmin, G. Janni, T. M. Moallem, D. A. Lappi, and P. T. Ohara, “Schwann cells are removed from the spinal cord after effecting recovery from paraplegia,” Journal of Neuroscience, vol. 20, no. 24, pp. 9215–9223, 2000. View at Google Scholar · View at Scopus
  40. J. R. Perlin, M. E. Lush, W. Z. Stephens, T. Piotrowski, and W. S. Talbot, “Neuronal neuregulin 1 type III directs Schwann cell migration,” Development, vol. 138, no. 21, pp. 4639–4648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. J. Sims, M. B. Durgun, and S. A. Gilmore, “Schwann cell invasion of ventral spinal cord: the effect of irradiation on astrocyte barriers,” Journal of Neuropathology and Experimental Neurology, vol. 57, no. 9, pp. 866–873, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Zawadzka, L. E. Rivers, S. P. J. Fancy et al., “CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination,” Cell Stem Cell, vol. 6, no. 6, pp. 578–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Bartus, J. Galino, N. D. James et al., “Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury,” Brain, vol. 139, no. 5, pp. 1394–1416, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. G. L. Hinks and R. J. M. Franklin, “Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-β1 gene expression during remyelination of experimentally-induced spinal cord demyelination,” Molecular and Cellular Neurosciences, vol. 14, no. 2, pp. 153–168, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Bansal, M. Kumar, K. Murray, R. S. Morrison, and S. E. Pfeiffer, “Regulation of FGF receptors in the oligodendrocyte lineage,” Molecular and Cellular Neurosciences, vol. 7, no. 4, pp. 263–275, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. J. C. Murtie, Y.-X. Zhou, T. Q. Le, A. C. Vana, and R. C. Armstrong, “PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination,” Neurobiology of Disease, vol. 19, no. 1-2, pp. 171–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Furusho, J. L. Dupree, K.-A. Nave, and R. Bansal, “Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness,” Journal of Neuroscience, vol. 32, no. 19, pp. 6631–6641, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Hashimoto, A. Nitta, H. Fukumitsu, H. Nomoto, L. Shen, and S. Furukawa, “Inflammation-induced GDNF improves locomotor function after spinal cord injury,” NeuroReport, vol. 16, no. 2, pp. 99–102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Schwartz, “Helping the body to cure itself: immune modulation by therapeutic vaccination for spinal cord injury,” Journal of Spinal Cord Medicine, vol. 26, no. 1, pp. S6–S10, 2003. View at Google Scholar · View at Scopus
  50. C. Figueiredo, T. F. Pais, J. R. Gomes, and S. Chatterjee, “Neuron-microglia crosstalk up-regulates neuronal FGF-2 expression which mediates neuroprotection against excitotoxicity via JNK1/2,” Journal of Neurochemistry, vol. 107, no. 1, pp. 73–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. L. E. Lillien and M. C. Raff, “Differentiation signals in the CNS: type-2 astrocyte development in vitro as a model system,” Neuron, vol. 5, no. 2, pp. 111–119, 1990. View at Publisher · View at Google Scholar · View at Scopus
  52. R. D. McKinnon, T. Matsui, M. Dubois-Dalcq, and S. A. Aaronsont, “FGF modulates the PDGF-driven pathway of oligodendrocyte development,” Neuron, vol. 5, no. 5, pp. 603–614, 1990. View at Publisher · View at Google Scholar · View at Scopus
  53. R. S. Morrison and J. de Vellis, “Growth of purified astrocytes in a chemically defined medium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 11, pp. 7205–7209, 1981. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Gonzalez, M. Berry, P. A. Maher, A. Logan, and A. Baird, “A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain,” Brain Research, vol. 701, no. 1-2, pp. 201–226, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Logan, S. A. Frautschy, A.-M. Gonzalez, and A. Baird, “A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury,” Journal of Neuroscience, vol. 12, no. 10, pp. 3828–3837, 1992. View at Google Scholar · View at Scopus
  56. J. F. Reilly and V. G. Kumari, “Alterations in fibroblast growth factor receptor expression following brain injury,” Experimental Neurology, vol. 140, no. 2, pp. 139–150, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Takami, Y. Kiyota, M. Iwane et al., “Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia,” Experimental Brain Research, vol. 97, no. 2, pp. 185–194, 1993. View at Publisher · View at Google Scholar · View at Scopus
  58. J. F. Reilly, P. A. Maher, and V. G. Kumari, “Regulation of astrocyte GFAP expression by TGF-β1 and FGF-2,” GLIA, vol. 22, no. 2, pp. 202–210, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. N. P. Pringle, W.-P. Yu, M. Howell, J. S. Colvin, D. M. Ornitz, and W. D. Richardson, “Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains,” Development, vol. 130, no. 1, pp. 93–102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. P. J. Albrecht, J. P. Dahl, O. K. Stoltzfus, R. Levenson, and S. W. Levison, “Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival,” Experimental Neurology, vol. 173, no. 1, pp. 46–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. P. J. Albrecht, J. C. Murtie, J. K. Ness et al., “Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production,” Neurobiology of Disease, vol. 13, no. 2, pp. 89–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. Z. C. Hesp, E. A. Goldstein, C. J. Miranda, B. K. Kaspar, and D. M. McTigue, “Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats,” Journal of Neuroscience, vol. 35, no. 3, pp. 1274–1290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. R. B. Tripathi and D. M. McTigue, “Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats,” Journal of Comparative Neurology, vol. 510, no. 2, pp. 129–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Pehar, P. Cassina, M. R. Vargas et al., “Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis,” Journal of Neurochemistry, vol. 89, no. 2, pp. 464–473, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Cassina, M. Pehar, M. R. Vargas et al., “Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis,” Journal of Neurochemistry, vol. 93, no. 1, pp. 38–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. D. J. Macaya, K. Hayakawa, K. Arai, and M. Spector, “Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury,” Biomaterials, vol. 34, no. 14, pp. 3591–3602, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Cheng, Y. Cao, and L. Olson, “Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function,” Science, vol. 273, no. 5274, pp. 510–513, 1996. View at Publisher · View at Google Scholar · View at Scopus
  68. Y.-S. Lee, I. Hsiao, and V. W. Lin, “Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats,” Journal of Neurotrauma, vol. 19, no. 10, pp. 1203–1216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. J. D. Guest, D. Hesse, L. Schnell, M. E. Schwab, M. B. Bunge, and R. P. Bunge, “Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts,” Journal of Neuroscience Research, vol. 50, no. 5, pp. 888–905, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. M. F. L. Meijs, L. Timmers, D. D. Pearse et al., “Basic fibroblast growth factor promotes neuronal survival but not behavioral recovery in the transected and Schwann cell implanted rat thoracic spinal cord,” Journal of Neurotrauma, vol. 21, no. 10, pp. 1415–1430, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. A. G. Rabchevsky, I. Fugaccia, A. Fletcher-Turner, D. A. Blades, M. P. Mattson, and S. W. Scheff, “Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury,” Journal of Neurotrauma, vol. 16, no. 9, pp. 817–830, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. A. G. Rabchevsky, I. Fugaccia, A. F. Turner, D. A. Blades, M. P. Mattson, and S. W. Scheff, “Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat,” Experimental Neurology, vol. 164, no. 2, pp. 280–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Kasai, T. Jikoh, H. Fukumitsu, and S. Furukawa, “FGF-2-responsive and spinal cord-resident cells improve locomotor function after spinal cord injury,” Journal of Neurotrauma, vol. 31, no. 18, pp. 1584–1598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. Y. Goldshmit, F. Frisca, A. R. Pinto et al., “Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury,” Brain and Behavior, vol. 4, no. 2, pp. 187–200, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. F. P. Guzen, J. G. Soares, L. M. De Freitas et al., “Sciatic nerve grafting and inoculation of FGF-2 promotes improvement of motor behavior and fiber regrowth in rats with spinal cord transection,” Restorative Neurology and Neuroscience, vol. 30, no. 3, pp. 265–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. S. Lee, C. Y. Lin, H. H. Jiang, M. Depaul, V. W. Lin, and J. Silver, “Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury,” Journal of Neuroscience, vol. 33, no. 26, pp. 10591–10606, 2013. View at Publisher · View at Google Scholar
  77. B. Haenzi, K. Ger-Barlag, H. Akhoundzadeh et al., “Overexpression of the fibroblast growth factor receptor 1 (FGFR1) in a model of spinal cord injury in rats,” PLoS ONE, vol. 11, no. 3, Article ID e0150541, 2016. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Follesa, J. R. Wrathall, and I. Mocchetti, “Increased basic fibroblast growth factor mRNA following contusive spinal cord injury,” Molecular Brain Research, vol. 22, no. 1–4, pp. 1–8, 1994. View at Publisher · View at Google Scholar · View at Scopus
  79. I. Mocchetti, S. J. Rabin, A. M. Colangelo, S. R. Whittemore, and J. R. Wrathall, “Increased basic fibroblast growth factor expression following contusive spinal cord injury,” Experimental Neurology, vol. 141, no. 1, pp. 154–164, 1996. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Koshinaga, H. R. Sanon, and S. R. Whittemore, “Altered acidic and basic fibroblast growth factor expression following spinal cord injury,” Experimental Neurology, vol. 120, no. 1, pp. 32–48, 1993. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Lang, X. Guo, M. Kerschensteiner, and F. M. Bareyre, “Single collateral reconstructions reveal distinct phases of corticospinal remodeling after spinal cord injury,” PLoS ONE, vol. 7, no. 1, Article ID e30461, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Jacobi, K. Loy, A. M. Schmalz et al., “FGF22 signaling regulates synapse formation during post-injury remodeling of the spinal cord,” The EMBO Journal, vol. 34, no. 9, pp. 1231–1243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Umemori, M. W. Linhoff, D. M. Ornitz, and J. R. Sanes, “FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain,” Cell, vol. 118, no. 2, pp. 257–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Cheng, B. Hoffer, I. Strömberg, D. Russell, and L. Olson, “The effect of glial cell line-derived neurotrophic factor in fibrin glue on developing dopamine neurons,” Experimental Brain Research, vol. 104, no. 2, pp. 199–206, 1995. View at Publisher · View at Google Scholar · View at Scopus
  85. M.-J. Lee, C. J. Chen, W.-C. Huang et al., “Regulation of chondroitin sulphate proteoglycan and reactive gliosis after spinal cord transection: effects of peripheral nerve graft and fibroblast growth factor 1,” Neuropathology and Applied Neurobiology, vol. 37, no. 6, pp. 585–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. I. A. Ferguson and E. M. Johnson Jr., “Fibroblast growth factor receptor-bearing neurons in the CNS: identification by receptor-mediated retrograde transport,” Journal of Comparative Neurology, vol. 313, no. 4, pp. 693–706, 1991. View at Publisher · View at Google Scholar · View at Scopus
  87. J. M. A. Laird, G. S. Mason, K. A. Thomas, R. J. Hargreaves, and R. G. Hill, “Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat,” Neuroscience, vol. 65, no. 1, pp. 209–216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  88. K. J. Anderson, D. Dam, S. Lee, and C. W. Cotman, “Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo,” Nature, vol. 332, no. 6162, pp. 360–361, 1988. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Blottner, C. Stapf, C. Meisinger, and C. Grothe, “Localization, differential expression and retrograde axonal transport suggest physiological role of FGF-2 in spinal autonomic neurons of the rat,” European Journal of Neuroscience, vol. 9, no. 2, pp. 368–377, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Blottner and T. Herdegen, “Neuroprotective fibroblast growth factor type-2 down-regulates the c-Jun transcription factor in axotomized sympathetic preganglionic neurons of adult rat,” Neuroscience, vol. 82, no. 1, pp. 283–292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Fisher, M.-E. Meadows, T. Do et al., “Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 15, no. 6, pp. 953–959, 1995. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Kawamata, N. E. Alexis, W. D. Dietrich, and S. P. Finklestein, “Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat,” Journal of Cerebral Blood Flow and Metabolism, vol. 16, no. 4, pp. 542–547, 1996. View at Google Scholar · View at Scopus
  93. P. B. Kirschner, R. Henshaw, J. Weise et al., “Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 15, no. 4, pp. 619–623, 1995. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Nozaki, S. P. Finklestein, and M. F. Beal, “Delayed administration of basic fibroblast growth factor protects against N-methyl-D-aspartate neurotoxicity in neonatal rats,” European Journal of Pharmacology, vol. 232, no. 2-3, pp. 295–297, 1993. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. D. Teng, I. Mocchetti, and J. R. Wrathall, “Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury,” European Journal of Neuroscience, vol. 10, no. 2, pp. 798–802, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Yamada, A. Kinoshita, E. Kohmura et al., “Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction,” Journal of Cerebral Blood Flow and Metabolism, vol. 11, no. 3, pp. 472–478, 1991. View at Publisher · View at Google Scholar · View at Scopus
  97. A. M. Gonzalez, L. S. Carman, M. Ong et al., “Storage, metabolism, and processing of 125I-fibroblast growth factor-2 after intracerebral injection,” Brain Research, vol. 665, no. 2, pp. 285–292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  98. Y. Goldshmit, T. E. Sztal, P. R. Jusuf, T. E. Hall, M. Nguyen-Chi, and P. D. Currie, “Fgf-dependent glial cell bridges facilitate spinal cord regeneration in Zebrafish,” Journal of Neuroscience, vol. 32, no. 22, pp. 7477–7492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. Y. Shen, A. P. Tenney, S. A. Busch et al., “PTPσ is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration,” Science, vol. 326, no. 5952, pp. 592–596, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. S. H. Ong, G. R. Guy, Y. R. Hadari et al., “FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors,” Molecular and Cellular Biology, vol. 20, no. 3, pp. 979–989, 2000. View at Publisher · View at Google Scholar · View at Scopus
  101. E. J. Williams, B. Mittal, F. S. Walsh, and P. Doherty, “FGF inhibits neurite outgrowth over monolayers of astrocytes and fibroblasts expressing transfected cell adhesion molecules,” Journal of Cell Science, vol. 108, no. 11, pp. 3523–3530, 1995. View at Google Scholar · View at Scopus
  102. M. Cheah, J. W. Fawcett, and B. Haenzi, “Differential regenerative ability of sensory and motor neurons,” Neuroscience Letters, 2016. View at Publisher · View at Google Scholar